Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash flows from operating activities:
Net income	$ 7,291,559	$ 6,857,988
Adjustments to reconcile net income to net cash (used in)/provided by operating activities:
Depreciation	519,765	82,180
Amortization	550,800	1,224,684
Unrealized currency gain	(76,765)
Bad debt expense	(207,261)	244,685
Inventory excess and obsolescence expense	12,234	211,822
Stock-based compensation expense	13,400,581	4,718,699
Gain on China transaction		(384,493)
Gain on lease cancellations	(14,669)	(152,112)
Changes in operating assets and liabilities:
Accounts receivable-net	(28,307,104)	(9,031,438)
Inventory-net	(103,920,057)	(598,665)
Prepaid expenses and other current assets	(8,202,588)	(561,752)
Accounts payable and accrued expenses	66,694,568	824,964
Other assets	(185,716)	43,259
Other liabilities	532,395	213,764
Deferred Tax Liability-net	(182,156)
Change in right-of-use asset and lease liability-net	30,465	149,925
Net cash (used in)/provided by operating activities	(52,063,949)	3,843,510
Cash flows from investing activities:
Proceeds from note receivable	1,885,724	1,331,011
Purchase of property and equipment	(2,395,302)	(416,671)
Net cash (used in)/provided by investing activities	(509,578)	914,340
Cash flows from financing activities:
Principal payments on finance lease obligations	(72,386)	(259,231)
Proceeds from capital raise	67,769,386	21,983,116
Proceeds from exercise of stock options	3,242,073	2,296,343
Net cash provided by financing activities	70,939,073	24,020,228
Effect on exchange rate changes on cash and cash equivalents	(236,365)	289,338
Net increase in cash and cash equivalents	18,129,181	29,067,416
Cash and cash equivalents at beginning of the period	43,248,021	23,090,682
Cash and cash equivalents at end of the period	61,377,202	52,158,098
Cash paid during period for:
Interest	5,364	299,394
Taxes	398,326
Non-cash investing and financing activities:
Goodwill		395,515
Other liabilities		$ (395,515)